{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:05:57Z","timestamp":1764608757806,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ahj.2025.03.021","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T16:52:03Z","timestamp":1744476723000},"page":"141-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rationale and design of the TADCLOT trial: A double blind randomized controlled trial comparing twice a day clopidogrel vs ticagrelor in reducing major cardiac events in patients with acute STEMI undergoing primary percutaneous coronary intervention"],"prefix":"10.1016","volume":"287","author":[{"given":"Abdul","family":"Hakeem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehangir","family":"Ali Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HamayaL","family":"Zeeshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan Ali","family":"Lakho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Inam","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashir","family":"Solangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romana","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhan","family":"Dilawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haroon","family":"Ishaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiza","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ejaz","family":"Ul Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waheed A","family":"Lehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakir","family":"Zada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobia","family":"Masood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadullah","family":"Humza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musa","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2025.03.021_bib0001","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.117.033325","article-title":"Relationship between operator volume and long-term outcomes after percutaneous coronary intervention","volume":"139","author":"Fanaroff","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.03.021_bib0002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jcin.2020.12.005","article-title":"Stent thrombosis risk over time on the basis of clinical presentation and platelet reactivity: analysis from ADAPT-DES","volume":"14","author":"Chau","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2025.03.021_bib0003","article-title":"Advancing acute MI care in densely populated low- and middle-income countries (LMICs): innovative stand-alone chest pain units for expedited triage and timely management","volume":"30","author":"Qamar","year":"2024","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/j.ahj.2025.03.021_bib0004","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/CIRCULATIONAHA.122.059122","article-title":"Cardiovascular diseases in Pakistan: imagining a postpandemic, postconflict future","volume":"147","author":"Samad","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.03.021_bib0005","article-title":"Acute and sub-acute stent thrombosis: frequency, predictors and features in patients undergoing primary percutaneous intervention at a tertiary care cardiac centre","volume":"26","author":"Tariq","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.ahj.2025.03.021_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacasi.2021.04.007","article-title":"Epidemiological features of cardiovascular disease in Asia","volume":"1","author":"Zhao","year":"2021","journal-title":"JACC Asia"},{"key":"10.1016\/j.ahj.2025.03.021_bib0007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5334\/gh.1112","article-title":"Incidence, predictors, and outcomes of acute and sub-acute stent thrombosis after emergency percutaneous coronary revascularization with drug-eluting stents: a prospective observational study","volume":"17","author":"Kumar","year":"2022","journal-title":"Glob Heart"},{"key":"10.1016\/j.ahj.2025.03.021_bib0008","doi-asserted-by":"crossref","first-page":"332","DOI":"10.37616\/2212-5043.1283","article-title":"Zwolle risk score for safety assessment of same-day discharge after primary percutaneous coronary intervention","volume":"33","author":"Ali Shah","year":"2021","journal-title":"J Saudi Heart Assoc"},{"key":"10.1016\/j.ahj.2025.03.021_bib0009","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.amjcard.2015.03.010","article-title":"Comparison of short- and long-term cardiac mortality in early versus late stent thrombosis (from Pooled PROTECT Trials)","volume":"115","author":"Secemsky","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2025.03.021_bib0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2025.03.021_bib0011","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/heartjnl-2015-308963","article-title":"PLATO Investigators. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention","volume":"102","author":"Velders","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2025.03.021_bib0012","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jacc.2016.03.512","article-title":"Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC\/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease","volume":"68","author":"Bittl","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.03.021_bib0013","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J."},{"key":"10.1016\/j.ahj.2025.03.021_bib0014","first-page":"3238","article-title":"ESC thrombosis Working Group. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis","volume":"36","author":"Andreotti","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2025.03.021_bib0015","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2025.03.021_bib0016","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"Mehta","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2025.03.021_bib0017","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1538-7836.2011.04216.x","article-title":"Clopidogrel 150 vs. 75 mg day\u22121 in patients undergoing percutaneous coronary intervention: a meta-analysis","volume":"9","author":"Hao","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ahj.2025.03.021_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100573","article-title":"CYP2C19 genotype prevalence and association with recurrent myocardial infarction in British\u2013South Asians treated with clopidogrel","volume":"2","author":"Magavern","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.ahj.2025.03.021_bib0019","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"Mega","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2025.03.021_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100572","article-title":"Clopidogrel pharmacogenomics: validation in a population of South-Asian ancestry","volume":"2","author":"Kreutz","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.ahj.2025.03.021_bib0021","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1038\/s41598-022-09679-8","article-title":"Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients","volume":"12","author":"Ahmed","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ahj.2025.03.021_bib0022","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.052430","article-title":"Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals","volume":"144","author":"Patel","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.03.021_bib0023","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4244\/EIJV4I2A39","article-title":"Antiplatelet response to the 150-mg maintenance dose of clopidogrel in patients with insufficient platelet inhibition after clopidogrel loading for elective coronary stent placement","volume":"4","author":"Trenk","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2025.03.021_bib0024","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.2011.1703","article-title":"Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease","volume":"306","author":"Mega","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2025.03.021_bib0025","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7326\/M21-3729","article-title":"Knowledge gaps, challenges, and opportunities in health and prevention research for Asian Americans, Native Hawaiians, and Pacific Islanders: a report from the 2021 National Institutes of Health Workshop","volume":"175","author":"Kanaya","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2025.03.021_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000112","article-title":"2022 ACC\/AHA key Data elements and definitions for chest pain and acute myocardial infarction: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Data Standards","volume":"15","author":"Anderson","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2025.03.021_bib0027","unstructured":"Sealed Envelope Ltd. Create a blocked randomisation list. Available from: https:\/\/www.sealedenvelope.com\/simple-randomiser\/v1\/lists (Accessed January 5, 2023)."},{"key":"10.1016\/j.ahj.2025.03.021_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2015.03.015","article-title":"PLATO Investigators. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: a retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"169","author":"Kang","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2025.03.021_bib0029","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.116.024823","article-title":"PRAGUE-18 study group. Prasugrel versus ticagrelor in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: multicenter randomized PRAGUE-18 study","volume":"134","author":"Motovska","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.03.021_bib0030","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"ATLANTIC investigators. Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ahj.2025.03.021_bib0031","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"ISAR-REACT 5 trial investigators. Ticagrelor or Prasugrel in patients with acute coronary syndromes","volume":"381","author":"Sch\u00fcpke","year":"2019","journal-title":"N Engl J Med."}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:59:39Z","timestamp":1762077579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870325001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"alternative-id":["S0002870325001036"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2025.03.021","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the TADCLOT trial: A double blind randomized controlled trial comparing twice a day clopidogrel vs ticagrelor in reducing major cardiac events in patients with acute STEMI undergoing primary percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2025.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}